Careium AB (SE:CARE)
:CARE
Want to see SE:CARE full AI Analyst Report?
Top Page
Careium AB
(CARE)
Select Model
Select Model
Rating:73Outperform
Price Target:
kr28.00
▲(13.82% Upside)
Action:Reiterated
Date:05/22/26
The score is driven primarily by improving financial stability (post-loss profitability and reduced leverage), tempered by recent margin compression and uneven free-cash-flow conversion. Technicals add support with a strong uptrend above key moving averages and positive MACD, while valuation is neutral with a mid-teens P/E and no dividend data to bolster returns.
Positive Factors
Recurring revenue from devices, software and services
Careium’s business centers on hardware, software platforms and recurring service contracts (connectivity, maintenance, monitoring). This installed-base model creates durable, contract-driven revenue and predictable service margins that support multi-year cash visibility and customer stickiness.
Negative Factors
Recent revenue decline
Reported revenue contraction (~12.7%) signals demand or contract-timing headwinds in core municipal and provider channels. Durable growth depends on renewing and expanding institutional contracts; continued top-line weakness would limit margin expansion and long-term return potential.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring revenue from devices, software and services
Careium’s business centers on hardware, software platforms and recurring service contracts (connectivity, maintenance, monitoring). This installed-base model creates durable, contract-driven revenue and predictable service margins that support multi-year cash visibility and customer stickiness.
Read all positive factors
Careium AB (CARE) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr598.42M
Dividend YieldN/A
Average Volume (3M)14.72K
Price to Earnings (P/E)18.6
Beta (1Y)0.49
Revenue Growth-0.13%
EPS Growth-36.54%
CountrySE
Employees548
SectorHealthcare
Sector Strength45
IndustrySecurity & Protection Services
Share Statistics
EPS (TTM)1.35
Shares Outstanding24,326,214
10 Day Avg. Volume10,828
30 Day Avg. Volume14,717
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)0.85
Price to Sales (P/S)0.68
P/FCF Ratio11.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.98
Revenue Forecast (FY)kr934.39M
Careium AB Business Overview & Revenue Model
Company Description
Careium AB (Publ), established in 1974 and headquartered in Malmö, Sweden, specializes in providing technologically advanced care solutions across numerous European nations, including Sweden, Norway, the United Kingdom, and the Netherlands. Their ...
How the Company Makes Money
Careium makes money by selling technology-enabled care solutions and related services to organizations that deliver or fund care. Key revenue streams typically include: (1) Hardware/device sales: revenue from supplying personal alarms and connecte...
Careium AB Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
78
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 866.30M | 854.10M | 870.70M | 824.60M | 725.10M | 587.50M |
| Gross Profit | 377.70M | 375.10M | 373.70M | 340.50M | 273.70M | 240.30M |
| EBITDA | 124.50M | 120.60M | 150.60M | 137.90M | 67.90M | 65.10M |
| Net Income | 33.00M | 35.80M | 58.40M | 37.90M | -8.60M | 4.70M |
Balance Sheet | ||||||
| Total Assets | 1.09B | 1.09B | 1.05B | 961.40M | 992.10M | 1.05B |
| Cash, Cash Equivalents and Short-Term Investments | 37.90M | 54.90M | 31.90M | 31.50M | 39.90M | 142.50M |
| Total Debt | 207.80M | 209.70M | 196.80M | 225.30M | 322.70M | 292.30M |
| Total Liabilities | 394.30M | 407.40M | 371.40M | 361.90M | 425.50M | 500.20M |
| Stockholders Equity | 698.50M | 681.50M | 678.20M | 599.50M | 566.60M | 551.50M |
Cash Flow | ||||||
| Free Cash Flow | 48.30M | 51.30M | 36.90M | 61.90M | -87.10M | -70.90M |
| Operating Cash Flow | 131.60M | 143.40M | 92.90M | 111.90M | -21.10M | -19.80M |
| Investing Cash Flow | -100.10M | -102.20M | -56.00M | -50.00M | -68.70M | -163.70M |
| Financing Cash Flow | -31.00M | -13.70M | -39.60M | -69.70M | -15.10M | 291.00M |
Careium AB Technical Analysis
Neutral
24.60
Price Trends
23.83
Positive
22.49
Positive
23.52
Positive
Market Momentum
0.42
Positive
50.60
Neutral
24.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CARE, the sentiment is Neutral. The current price of 24.6 is below the 20-day moving average (MA) of 25.84, above the 50-day MA of 23.83, and above the 200-day MA of 23.52, indicating a neutral trend. The MACD of 0.42 indicates Positive momentum. The RSI at 50.60 is Neutral, neither overbought nor oversold. The STOCH value of 24.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:CARE.
Careium AB Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | kr598.42M | 18.58 | ― | ― | -0.13% | -36.54% | |
68 Neutral | kr569.68M | 2.99 | 4.07% | 17.16% | -9.22% | ― | |
67 Neutral | kr966.23M | 22.60 | ― | 2.85% | -1.85% | -22.36% | |
52 Neutral | kr112.19M | -0.61 | -45.32% | ― | 1.81% | 68.16% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | kr69.78M | -5.92 | -1.58% | ― | -8.81% | 33.71% | |
46 Neutral | kr120.56M | -18.40 | ― | ― | 15.57% | 88.38% |
* Healthcare Sector Average
SE:CARE
Careium AB
25.20
-7.30
-22.46%
SE:LEVEL
Nordic LEVEL Group AB Class B
0.32
-0.13
-28.41%
SE:CNCJO.B
Concejo AB Class B
48.40
13.92
40.37%
SE:IRIS
Irisity AB
0.28
0.00
0.00%
SE:TSEC
Tempest Security AB
11.50
1.68
17.11%
SE:FIRE
Firefly AB
161.00
-4.44
-2.68%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.